Rheumatoid Arthritis Market Segmentation by Leading Players and Opportunity - Global Forecasts to 2023
Global Rheumatoid arthritis market Information, by drug type (Nonsteroidal anti-inflammatory drug type (NSAID), Steroids, Biologic agents) by diagnosis (C-Reactive Protein (CRP) Test, CCP, ESR test) by treatment (Synovectomy, Tendon repair, Joint fusion) - Forecast to 2022
Market Highlights
Rheumatoid arthritis is a
chronic inflammatory condition that possible can distress more than just the
joints. It is found that in some individuals, the disorder also can damage a
various parts of body system, including the lungs, skin, eyes, heart and blood
vessels. The global
rheumatoid arthritis market is expected to grow at a healthy CAGR of ~4% during the forecast period
2017-2022.
The major factors
influencing the growth of the market include high number of individuals
suffering from the autoimmune disease, it has been observed that this disease
is found three times more in women than as men. The reason behind gender gap is
still unknown, but researchers say it’s something to do with the hormones.
According to Health Union, LLC is one of the common chronic disease that
affects approximately 1.3 million Americans and as much as 1% of the global
population. Big pharmaceutical companies taking steps for the development of
products related to rheumatoid arthritis is further influencing the growth of
the market. Moreover there is a huge opportunity in developing nations that is
grabbed by various market players for expanding their presence in the region.
The market is forecast to demonstrate a steady growth by 2022, surpassing its
previous growth records in terms of value with a striking CAGR during the
anticipated period 2017–2022.
Avail
a Free Sample@ https://www.marketresearchfuture.com/sample_request/1658
Characterized by the
presence of several well-established and small players, the global market of
rheumatoid arthritis appears to be highly competitive and fragmented. With
well-established market in the North America region major companies like Pfizer
Inc., Eli Lilly and Company, Bristol-Myers Squibb Company, Vertex
Pharmaceuticals Incorporated, and various others have their home in the region
and generate maximum market share. These companies have expanded their
operating unit in various other emerging regions as well. Moreover the other
small and medium scale players are generating revenue from local market.
Intended Audience
- Pharmaceutical companies
- Rheumatoid arthritis treatment centers
- Contract Research Organizations (CROs)
- Research and Development (R&D) Companies
- Government Research Laboratories
- Independent Research Laboratories
- Government and Independent Regulatory
Authorities
- Market Research and Consulting Service
Providers
- Medical Research Laboratories
- Academic Medical Institutes and Universities
The market for rheumatoid
arthritis is highly competitive with companies focusing on the development of
oral drug and treatment. U.S based pharmaceutical company Pfizer is one of the
leaders in the market. The company in February 2016, announced the approval of
its product XELJANZ XR (tofacitinib citrate) by the U.S. Food and
Drug Administration (FDA). The 11mg drug product has been approved for daily
once treatment of medium to severe rheumatoid arthritis. XELJANZ has been
approved in more than 45 countries across the globe for the treatment of
moderate to severe RA. The company has been involved in this market for more
than 60 years and being the leader in the market continues for the development
of the market.
Global Rheumatoid Arthritis
Market - Regional Analysis
The global market is
segmented into the various regions including Americas, Europe, Asia Pacific,
and the Middle East & Africa. The Americas accounts for the largest market
share of about more than ~38 market share due to increasing patient pool
visiting professionals due to rheumatoid arthritis and favourable governmental
conditions for research and development. According to the study conducted by
the Centers for Disease Control and Prevention in March 2017 it was estimated
that about 54.4 million U.S. adults suffer from arthritis that is approximately
about 25% of its population. Arthritis is the key cause of disability, and
causing pain, aching, stiffness, and swelling of the joints. The most common
type of arthritis is rheumatoid arthritis & osteoarthritis. According to
the same study it is expected that by 2040, 78 million i.e. 26% of the U.S.
adults of age 18 years or older are anticipated to have doctor-diagnosed
arthritis.
Europe is the second
largest market of rheumatoid. U.K. the fastest growing market rheumatoid
arthritis in the Europe. According to the National Rheumatoid Arthritis Society
(NRAS) it is estimated that approximately 690,000 people suffer from rheumatoid
arthritis across the UK. Furthermore government taking initiates for the
awareness of rheumatoid arthritis is influencing the growth of the market.
Asia Pacific expected to be
the fastest growing region. The Asia Pacific region accounting for more 60% of
the world's population has provided a great opportunity for researchers to
study the epidemiology, pathogenesis and influencing various manufacturers for
the expansion of their unit in this region. There has been huge development for
the treatment of rheumatoid arthritis since the formation of the Asia Pacific
League of Associations for Rheumatology (APLAR) in 1963. Due to various
developments in the region there is potential growth in the region.
The Middle East &
Africa holds the least share in the rheumatoid arthritis market due to lack of
awareness, less emphasis on research and development activities, and poor
medical facilities.
Access Report Details @ https://www.marketresearchfuture.com/reports/rheumatoid-arthritis-market-1658
The report for Global market by Market
Research Future comprises of extensive primary research along with the detailed
analysis of qualitative as well as quantitative aspects by various industry
experts, key opinion leaders to gain a deeper insight of the market and
industry performance. The report gives a clear picture of the current market
scenario which includes past and estimated future market size with respect to
value and volume, technological advancement, macro economical and governing
factors in the market. The report provides detail information about and
strategies used by top key players in the industry. The report also gives a
broad study of the different market segments and regions.
Key Players
Pfizer Inc. (U.S), Eli
Lilly and company (U.S), Bristol-Myers Squibb Company (U.S), F. Hoffmann-La
Roche Ltd (Switzerland), Novartis AG (Switzerland), Vertex Pharmaceuticals
Incorporated (U.S), Sanofi (France), AstraZeneca (U.K) are some of the
prominent players at the forefront of competition in the Global Rheumatoid
Arthritis Market and are profiled in MRFR Analysis.
TOC:
1.
Report Prologue
2. Market
Introduction
2.1
Definition
2.2 Scope of the
Study
2.2.1
Research Objective
2.2.2
Assumptions
2.2.3
Limitations
3. Research
Methodology
3.1 Introduction
3.2 Primary
Research
3.3 Secondary research
3.4 Market Size
Estimation
TOC…Continued
Ask
Questions to Expertise @ https://www.marketresearchfuture.com/enquiry/1658
About Market Research Future:
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients. Our
market research studies by Components, Application, Logistics and market
players for global, regional, and country level market segments, enable our
clients to see more, know more, and do more, which help to answer all their
most important questions.
In order to stay updated with technology and work
process of the industry, MRFR often plans & conducts meet with the industry
experts and industrial visits for its research analyst members.
Contact Us:
Market
Research Future
Phone: +1 646 845 9312
Comments
Post a Comment